Manufacturers may expect significant levels of competition, specifically within the GLP-1 RA class, and will need to differentiate their assets and value proposition to remain competitive and maintain and/or grow their market share
Like insulins, GLP-1-RAs will possibly be included in volume-based procurement (VBP), a program known for sharp price cuts of products for bulk purchases by hospitals
So those indirect winds we are starting to look at like, wow, there's some benefit to your brain as well
Our email address is [email protected] Well reply with your all access pass to the course
The mechanism is not that semaglutide alters estrogen or progestin metabolism at the cytochrome P450 level
However, tirzepatide already provides significant weight loss results for many patients while offering a balance between effectiveness and tolerability